Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Feldenkrais vs. Task Oriented Gait Training on Diabetic Peripheral Neuropathy (FEToG-DPN)

4 de septiembre de 2026 actualizado por: Dr. Marium Zafar, University of Faisalabad

Comparative Effects of Feldenkrais Exercises and Task Oriented Gait Training in Patients With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy (DPN) causes balance problems, falls, and sensory loss in the feet. This study compares two non-drug exercise programs to see which works better. The first program is Feldenkrais exercises, which focus on movement awareness and retraining the brain. The second program is Task Oriented Gait Training, which practices specific walking tasks. Researchers will measure balance, joint position sense, touch sensation, fear of falling, and quality of life. Forty participants will be split into two groups. The study will last 12 weeks.

Descripción general del estudio

Descripción detallada

This study is a single-blinded, randomized clinical trial. Forty participants with Diabetic Peripheral Neuropathy (DPN) will be recruited from Shahid Heera's Health Clinic and Madinah Teaching Hospital in Faisalabad. Participants will be screened using the Michigan Neuropathy Screening Instrument (MNSI). Inclusion criteria include participants aged 45-55 years with type 1 or type 2 diabetes, a history of at least one fall in the past six months, a body mass index between 18.5 and 29.9, controlled blood glucose levels, and a Berg Balance Scale score between 21 and 40. Participants will be excluded if they have foot ulcers, lower leg amputation, Charcot foot, retinopathy, hypertension, or are already receiving rehabilitation.

Eligible participants will be randomly allocated into two groups of twenty using a computer-generated method. Group A will receive Feldenkrais exercises. Group B will receive Task Oriented Gait Training. Both groups will attend two sessions per week for twelve weeks. Each session lasts sixty minutes, consisting of a ten-minute warm-up, a forty-to-forty-five-minute main exercise session, and a ten-minute cool-down. Outcome measures will be recorded at baseline, the sixth week, and the twelfth week. The primary outcome measures are static and dynamic balance (Berg Balance Scale), ankle joint proprioception (joint position sense test), and tactile sensation (monofilament test). The secondary outcome measures are somatosensory postural control (Cumulative Somatosensory Impairment Index), fear of falling (Fall Efficacy Scale), self-awareness learning (educational brochure), and quality of life (SF-36 Questionnaire). SPSS version 20 will be used for statistical analysis.

Tipo de estudio

Intervencionista

Inscripción (Actual)

40

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Punjab Province
      • Faisalābad, Punjab Province, Pakistán, 3800
        • The University of Faisalabad

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Age ranges from 45-55 years
  • Diagnosed type 1 and type 2 diabetes
  • Suffered from a fall in last 6 months
  • MNSI Questionnaire scored > 2/13
  • MNSI physical assessment scored > 4/10
  • BMI = 18.5 - 29.9
  • Controlled blood glucose level
  • Berg Balance scale = 21-40
  • Willingness to participate and provide consent

Exclusion Criteria:

  • Presence of ulcers at foot
  • Lower leg amputation
  • Charcot foot
  • Retinopathy
  • Hypertension
  • Already receiving rehabilitation
  • History of trauma or fracture
  • Any related orthopedic conditions
  • CVS related conditions
  • Autonomic neuropathy

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Feldenkrais Exercises
Participants perform Feldenkrais exercises for 40 minutes per session, focusing on somatosensory re-education, axial movements, and balance.
This intervention includes 16 specific movement lessons (e.g., turning improvement, weight transference, sensing the feet, walking in tandem). The protocol is derived from Mazuelas et al. 2024. Sessions are 40 minutes, twice a week for 12 weeks, guided by a physiotherapist.
Warm up exercises: Warm up exercises before the start of training exercises for about ten minutes. These include: • Leg swings (forward and backward) • Side to side leg swings • Leg kicks 20 reps/side • Standing on tip toes • Mild stretching Cool down exercises: Cool Down exercises after the end of training exercises for about ten minutes to induce relaxation. These include: • Deep breathing exercise • Abdominal breathing exercise • Leg swings • Standing on tip toes • Mild stretching
Comparador activo: Task Oriented Gait Training
Participants perform Task Oriented Gait Training for 45 minutes per session, focusing on functional tasks like walking on surfaces, changing directions, and obstacle negotiation.
Warm up exercises: Warm up exercises before the start of training exercises for about ten minutes. These include: • Leg swings (forward and backward) • Side to side leg swings • Leg kicks 20 reps/side • Standing on tip toes • Mild stretching Cool down exercises: Cool Down exercises after the end of training exercises for about ten minutes to induce relaxation. These include: • Deep breathing exercise • Abdominal breathing exercise • Leg swings • Standing on tip toes • Mild stretching
This intervention includes functional tasks such as walking with reduced base of support, obstacle crossing, and ramp walking. The protocol is derived from Salsabili et al. 2015. Sessions are 45 minutes, twice a week for 12 weeks.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Berg Balance Scale Score
Periodo de tiempo: Baseline, Week 6, Week 12
The Berg Balance Scale (BBS) measures static and dynamic balance. It contains 14 items scored from 0 to 4. Total score ranges from 0 to 56. Higher scores indicate better balance.
Baseline, Week 6, Week 12
Change in Ankle Joint Proprioception
Periodo de tiempo: Baseline, Week 6, Week 12
Measured using the Joint Position Sense Test (JPST) with a goniometer. The participant actively reproduces a target joint angle. The difference in degrees between the target and the reproduction is recorded. Smaller differences indicate better proprioception.
Baseline, Week 6, Week 12
Change in Tactile Sensation
Periodo de tiempo: Baseline, Week 6, Week 12
Measured using the Semmes-Weinstein Monofilament (10g). The filament is applied to 10 sites on the plantar surface of the foot. The number of correctly detected applications out of 10 is recorded. Higher scores indicate better sensation.
Baseline, Week 6, Week 12

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Cumulative Somatosensory Impairment Index (CSII)
Periodo de tiempo: Baseline, Week 6, Week 12
Measures somatosensory postural control and functional awareness. Scale range and specific scoring will be calculated per the CSII manual.
Baseline, Week 6, Week 12
Change in Fear of Falling
Periodo de tiempo: Baseline, Week 6, Week 12
Measured using the Fall Efficacy Scale (FES). Participants rate confidence in performing 10 activities without falling. Scores range from 10 (high confidence) to 100 (low confidence).
Baseline, Week 6, Week 12
Change in Quality of Life
Periodo de tiempo: Baseline, Week 6, Week 12
Measured using the SF-36 Questionnaire. This tool assesses physical and mental health across 8 domains. Scores are transformed into a scale from 0 to 100. Higher scores indicate better quality of life.
Baseline, Week 6, Week 12
Self-Awareness Learning Adherence
Periodo de tiempo: Week 12
Measured by the return of a structured educational brochure checklist. Participants report if they performed prescribed home self-learning activities.
Week 12

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de febrero de 2026

Finalización primaria (Actual)

1 de abril de 2026

Finalización del estudio (Actual)

28 de mayo de 2026

Fechas de registro del estudio

Enviado por primera vez

23 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

23 de mayo de 2026

Publicado por primera vez (Actual)

1 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

10 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

4 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir